DD229153A5 - Verfahren zur herstellung von indanyl-derivate - Google Patents

Verfahren zur herstellung von indanyl-derivate Download PDF

Info

Publication number
DD229153A5
DD229153A5 DD84269890A DD26989084A DD229153A5 DD 229153 A5 DD229153 A5 DD 229153A5 DD 84269890 A DD84269890 A DD 84269890A DD 26989084 A DD26989084 A DD 26989084A DD 229153 A5 DD229153 A5 DD 229153A5
Authority
DD
German Democratic Republic
Prior art keywords
indanyl
producing
compounds
derivatives
indanyl derivatives
Prior art date
Application number
DD84269890A
Other languages
German (de)
English (en)
Inventor
Karl Petzoldt
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of DD229153A5 publication Critical patent/DD229153A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/02Amides, e.g. chloramphenicol or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor
    • C12N1/145Fungal isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/645Fungi ; Processes using fungi
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/645Fungi ; Processes using fungi
    • C12R2001/66Aspergillus
    • C12R2001/685Aspergillus niger

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Botany (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pulmonology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
DD84269890A 1983-11-28 1984-11-26 Verfahren zur herstellung von indanyl-derivate DD229153A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833343331 DE3343331A1 (de) 1983-11-28 1983-11-28 Verfahren zur herstellung von indanyl-derivaten und deren verwendung

Publications (1)

Publication Number Publication Date
DD229153A5 true DD229153A5 (de) 1985-10-30

Family

ID=6215683

Family Applications (1)

Application Number Title Priority Date Filing Date
DD84269890A DD229153A5 (de) 1983-11-28 1984-11-26 Verfahren zur herstellung von indanyl-derivate

Country Status (18)

Country Link
US (1) US4696948A (da)
EP (1) EP0143403B1 (da)
JP (1) JPS60199394A (da)
AT (1) ATE62511T1 (da)
AU (1) AU568701B2 (da)
CA (1) CA1245589A (da)
CS (1) CS244844B2 (da)
DD (1) DD229153A5 (da)
DE (2) DE3343331A1 (da)
DK (1) DK561484A (da)
ES (1) ES537971A0 (da)
FI (1) FI77893C (da)
GR (1) GR81056B (da)
HU (1) HU193238B (da)
IL (1) IL73657A (da)
NO (1) NO164845C (da)
PT (1) PT79556B (da)
ZA (1) ZA849287B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0753725B2 (ja) * 1987-10-08 1995-06-07 富山化学工業株式会社 4h―1―ベンゾピラン―4―オン誘導体およびその塩、それらの製造法並びにそれらを含有する抗炎症剤
US5409944A (en) * 1993-03-12 1995-04-25 Merck Frosst Canada, Inc. Alkanesulfonamido-1-indanone derivatives as inhibitors of cyclooxygenase
US5500359A (en) * 1993-09-27 1996-03-19 Solvay Enzymes, Inc. Method for producing a therapeautic composition for papillomavirus-induced tumors with aspergillus niger
AU4479096A (en) * 1995-01-31 1996-08-21 Merck Frosst Canada Inc. 5-methanesulfonamido-3h-isobenzofuran-1-ones as inhibitors of cyclooxygenase-2

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2965279D1 (en) * 1978-07-27 1983-06-01 Schering Ag Indanyl derivatives, process for their preparation and pharmaceutical compositions containing these compounds
DE3103372A1 (de) * 1981-01-27 1982-09-02 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue indanyl-derivate, ihre herstellung und verwendung
DE3208079A1 (de) * 1982-03-04 1983-09-08 Schering AG, 1000 Berlin und 4709 Bergkamen Neue indanyl-derivate, ihre herstellung und verwendung

Also Published As

Publication number Publication date
EP0143403A2 (de) 1985-06-05
AU3584484A (en) 1985-06-06
IL73657A0 (en) 1985-02-28
DE3343331A1 (de) 1985-06-05
PT79556A (de) 1984-12-01
ZA849287B (en) 1985-07-31
PT79556B (de) 1986-09-15
ES8600736A1 (es) 1985-11-01
ATE62511T1 (de) 1991-04-15
JPS60199394A (ja) 1985-10-08
CA1245589A (en) 1988-11-29
FI77893B (fi) 1989-01-31
DK561484D0 (da) 1984-11-27
FI844644L (fi) 1985-05-29
HUT36499A (en) 1985-09-30
EP0143403B1 (de) 1991-04-10
US4696948A (en) 1987-09-29
IL73657A (en) 1987-10-30
NO164845B (no) 1990-08-13
AU568701B2 (en) 1988-01-07
NO164845C (no) 1990-11-21
CS244844B2 (en) 1986-08-14
ES537971A0 (es) 1985-11-01
EP0143403A3 (en) 1987-07-22
FI77893C (fi) 1989-05-10
FI844644A0 (fi) 1984-11-27
JPH054069B2 (da) 1993-01-19
DK561484A (da) 1985-05-29
NO844702L (no) 1985-05-29
DE3484422D1 (de) 1991-05-16
GR81056B (en) 1985-03-26
HU193238B (en) 1987-08-28

Similar Documents

Publication Publication Date Title
DE3051175C2 (da)
CH615159A5 (da)
EP0000560B1 (de) Verfahren zur Herstellung von optisch aktiven alpha-Hydroxycarbonsäuren
DE2343587A1 (de) Verfahren zur herstellung von 2-ketol-gulonsaeure
DE2631048C3 (de) Verfahren zur Herstellung von D-Phenylglycin
DE2715255A1 (de) Anthracyclinglykoside
DD229153A5 (de) Verfahren zur herstellung von indanyl-derivate
DE69908569T2 (de) Verfahren zur herstellung von fexofenadin
DE2528984C3 (de) Bestatin, dessen Verwendung und Verfahren zu dessen Herstellung
DE2712861C2 (de) 17-Acetoxy-6-chlor-15β-hydroxy-1α,2α-methylen-4,6-pregnadien-3,20-dion, Verfahren zu seiner Herstellung und dieses enthaltende Arzneimittel
EP0559116A2 (de) Mikrobiologisches Verfahren zur Hydroxylierung von Stickstoff-Heterocyclus-Carbonsäuren
DD239611A5 (de) Verfahren zur herstellung neuer saframycin a-derivaten
DE69528296T2 (de) Mikrobiologisches Verfahren zur Transformation von 17-beta-Carboxy-substituierten 3-Oxo-4-Azasteroiden und die Verwendung solcher Produkte als Inhibitoren des Enzyms 5-alpha-Reduktase
DE2839033A1 (de) 3-oxo-4-pregnen-20 alpha -carbonsaeure- derivate, ihre herstellung und verwendung
DE1643149A1 (de) Verfahren zur Oxydation von Adamantanverbindungen
DE3243924A1 (de) Mycotrienin-aehnliche verbindungen, verfahren zu deren herstellung und diese enthaltende arzneimittel
DE4410449C2 (de) Melithiazole A und B, Herstellungsverfahren, Mittel mit einem Gehalt an Melithiazol A und/oder B und Melittangium lichenicola DSM 9004 mit der Fähigkeit, Melithiazole A und B zu bilden
DE2849393C2 (de) Verfahren zur biotechnischen Herstellung von 2,5-Diketogluconsäure
DE3019450A1 (de) Verfahren zur gewinnung von glucosedehydrogenase und hierfuer geeigneter mikroorganismus
EP0019148A1 (de) Antibiotikum zur Unterdrückung des Wachstums von Mikroorganismen sowie dessen Herstellung durch Fermentation
DE3031334C2 (de) Mikrobiologisches Verfahren zur Herstellung von Cholansäurederivaten
DE2921052C2 (da)
DE2450106C2 (de) Neue 1 α-Hydroxysteroide, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE2453069A1 (de) Neue glykoside
EP0019162B1 (de) 12-alpha-Hydroxysteroide und deren Herstellung

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee